Vickroy T W, Roeske W R, Yamamura H I
Life Sci. 1984 Dec 3;35(23):2335-43. doi: 10.1016/0024-3205(84)90525-3.
This report describes the membrane binding properties of [3H]hemicholinium-3 ([3H]HC-3), a selective inhibitor of sodium-dependent high-affinity choline uptake (SDHACU) in cholinergic nerve terminals. Under the described assay conditions, [3H]HC-3 bind with a saturable population of high-affinity (apparent Kd = 1.9 nM) CNS membrane sites having the regional distribution: striatum much greater than hippocampus greater than cerebral cortex greater than cerebellum. High-affinity [3H]HC-3 binding is entirely dependent upon the presence of sodium chloride (EC50 = 35-50 mM) and is markedly reduced when other salts of sodium or monovalent ions are substituted. [3H]HC-3 binding is inhibited by choline (Ki = 6 microM) and acetylcholine (Ki = 35 microM) but markedly less sensitive to other cholinergic agents and metabolic inhibitors. In light of the similar ionic dependencies, regional distributions and pharmacological specificities of [3H]HC-3 binding and SDHACU, closely associated sites may be involved in both processes.
本报告描述了[3H]半胆碱-3([3H]HC-3)的膜结合特性,[3H]HC-3是胆碱能神经末梢中钠依赖性高亲和力胆碱摄取(SDHACU)的选择性抑制剂。在所描述的测定条件下,[3H]HC-3与具有区域分布的高亲和力(表观Kd = 1.9 nM)中枢神经系统膜位点的可饱和群体结合:纹状体远大于海马体大于大脑皮层大于小脑。高亲和力[3H]HC-3结合完全依赖于氯化钠的存在(EC50 = 35 - 50 mM),当用其他钠盐或单价离子替代时,结合明显减少。[3H]HC-3结合受到胆碱(Ki = 6 microM)和乙酰胆碱(Ki = 35 microM)的抑制,但对其他胆碱能药物和代谢抑制剂的敏感性明显较低。鉴于[3H]HC-3结合和SDHACU具有相似的离子依赖性、区域分布和药理学特异性,密切相关的位点可能参与这两个过程。